Loading...

BridgeBio Pharma, Inc.

BBIO•NASDAQ
Healthcare
Biotechnology
$47.29
$-1.79(-3.65%)

BridgeBio Pharma, Inc. (BBIO) Stock Overview

Explore BridgeBio Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.8/100

Key Financials

Market Cap9B
P/E Ratio-11.54
EPS (TTM)$-4.13
ROE0.51%
Fundamental Analysis

AI Price Forecasts

1 Week$42.78
1 Month$35.99
3 Months$32.92
1 Year Target$37.93

BBIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BridgeBio Pharma, Inc. (BBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.54, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $37.93.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.54 and a market capitalization of 9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.73%
5-Day Change
-3.18%
1-Month Change
2.90%
3-Month Change
11.11%
6-Month Change
29.45%
Year-to-Date (YTD) Change
14.57%
1-Year Change
18.22%
3-Year Change
198.34%
5-Year Change
18.87%
All-Time (Max) Change
17.28%

Contact Information

https://www.bridgebio.com
650 391 9740
421 Kipling Street, Palo Alto, CA, 94301

Company Facts

725 Employees
IPO DateJun 27, 2019
CountryUS
Actively Trading

Frequently Asked Questions

;